These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15948916)

  • 1. Lessons learnt in conducting a clinical drug trial in children with Asperger Syndrome.
    Mathai J; Bourne A; Cranswick N
    Australas Psychiatry; 2005 Jun; 13(2):173-5. PubMed ID: 15948916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertraline and the Cheshire cat in geriatric depression.
    Carroll BJ
    Am J Psychiatry; 2004 Apr; 161(4):759; author reply 759-61. PubMed ID: 15056533
    [No Abstract]   [Full Text] [Related]  

  • 3. Sertraline and the Cheshire cat in geriatric depression.
    Carroll BJ
    Am J Psychiatry; 2004 Jun; 161(6):1145-6. PubMed ID: 15169734
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitor treatment of major depressive disorder in children and adolescents.
    Newcorn JH
    Curr Psychiatry Rep; 2004 Apr; 6(2):85-7. PubMed ID: 15038909
    [No Abstract]   [Full Text] [Related]  

  • 5. Early augmentation of sertraline with methylphenidate.
    Postolache TT; Rosenthal RN; Hellerstein DJ; Aromin R; Kelton GM; Muran JC; Londono JH
    J Clin Psychiatry; 1999 Feb; 60(2):123-4. PubMed ID: 10084641
    [No Abstract]   [Full Text] [Related]  

  • 6. Placebo-controlled trial of sertraline in the treatment of binge eating disorder.
    McElroy SL; Casuto LS; Nelson EB; Lake KA; Soutullo CA; Keck PE; Hudson JI
    Am J Psychiatry; 2000 Jun; 157(6):1004-6. PubMed ID: 10831483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
    Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B
    Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
    Ravindran AV; Guelfi JD; Lane RM; Cassano GB
    J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
    Pollack MH; Otto MW; Worthington JJ; Manfro GG; Wolkow R
    Arch Gen Psychiatry; 1998 Nov; 55(11):1010-6. PubMed ID: 9819070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacologic treatment of Asperger syndrome].
    Yamada S
    Nihon Rinsho; 2007 Mar; 65(3):522-6. PubMed ID: 17354570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
    March JS; Biederman J; Wolkow R; Safferman A; Mardekian J; Cook EH; Cutler NR; Dominguez R; Ferguson J; Muller B; Riesenberg R; Rosenthal M; Sallee FR; Wagner KD; Steiner H
    JAMA; 1998 Nov; 280(20):1752-6. PubMed ID: 9842950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome.
    O'Reardon JP; Allison KC; Martino NS; Lundgren JD; Heo M; Stunkard AJ
    Am J Psychiatry; 2006 May; 163(5):893-8. PubMed ID: 16648332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
    Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K;
    Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
    Ninan PT; Koran LM; Kiev A; Davidson JR; Rasmussen SA; Zajecka JM; Robinson DG; Crits-Christoph P; Mandel FS; Austin C
    J Clin Psychiatry; 2006 Jan; 67(1):15-22. PubMed ID: 16426083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms.
    Oliveto A; Poling J; Mancino MJ; Williams DK; Thostenson J; Pruzinsky R; Gonsai K; Sofuoglu M; Gonzalez G; Tripathi S; Kosten TR
    Addiction; 2012 Jan; 107(1):131-41. PubMed ID: 21707811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
    Lustman PJ; Clouse RE; Nix BD; Freedland KE; Rubin EH; McGill JB; Williams MM; Gelenberg AJ; Ciechanowski PS; Hirsch IB
    Arch Gen Psychiatry; 2006 May; 63(5):521-9. PubMed ID: 16651509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction.
    O'Connor CM; Glassman AH; Harrison DJ
    J Clin Psychiatry; 2005 Mar; 66(3):346-52. PubMed ID: 15766301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early coadministration of clonazepam with sertraline for panic disorder.
    Goddard AW; Brouette T; Almai A; Jetty P; Woods SW; Charney D
    Arch Gen Psychiatry; 2001 Jul; 58(7):681-6. PubMed ID: 11448376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline for recurrent major depression.
    Smith A; Jainer AK; Bennet C
    Am J Psychiatry; 2005 May; 162(5):1025-6. PubMed ID: 15863821
    [No Abstract]   [Full Text] [Related]  

  • 20. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
    Kornstein SG; Schatzberg AF; Thase ME; Yonkers KA; McCullough JP; Keitner GI; Gelenberg AJ; Davis SM; Harrison WM; Keller MB
    Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.